|
Name |
Peniprequinolone
|
Molecular Formula | C22H25NO5 | |
IUPAC Name* |
(3R,4R)-4,5-dihydroxy-3-methoxy-4-(4-methoxyphenyl)-6-(3-methylbut-2-enyl)-1,3-dihydroquinolin-2-one
|
|
SMILES |
CC(=CCC1=C(C2=C(C=C1)NC(=O)[C@@H]([C@]2(C3=CC=C(C=C3)OC)O)OC)O)C
|
|
InChI |
InChI=1S/C22H25NO5/c1-13(2)5-6-14-7-12-17-18(19(14)24)22(26,20(28-4)21(25)23-17)15-8-10-16(27-3)11-9-15/h5,7-12,20,24,26H,6H2,1-4H3,(H,23,25)/t20-,22+/m0/s1
|
|
InChIKey |
ZRZQXSGEIJXJEO-RBBKRZOGSA-N
|
|
Synonyms |
peniprequinolone; (3R,4R)-4,5-dihydroxy-3-methoxy-4-(4-methoxyphenyl)-6-(3-methylbut-2-en-1-yl)-3,4-dihydroquinolin-2(1H)-one; (3R,4R)-4,5-dihydroxy-3-methoxy-4-(4-methoxyphenyl)-6-(3-methylbut-2-enyl)-1,3-dihydroquinolin-2-one; Peniprequinolone_120176; MLS000876990; CHEMBL516699; MEGxm0_000249; ACon0_000817; ACon1_002367; CHEBI:181572; HMS2267M24; ZINC13660211; NCGC00169912-01; NCGC00169912-03; SMR000440679; BRD-K17006545-001-01-3
|
|
CAS | NA | |
PubChem CID | 16681748 | |
ChEMBL ID | CHEMBL516699 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 383.4 | ALogp: | 3.0 |
HBD: | 3 | HBA: | 5 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 88.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 28 | QED Weighted: | 0.682 |
Caco-2 Permeability: | -4.712 | MDCK Permeability: | 0.00000846 |
Pgp-inhibitor: | 0.926 | Pgp-substrate: | 0.176 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.827 |
30% Bioavailability (F30%): | 0.444 |
Blood-Brain-Barrier Penetration (BBB): | 0.367 | Plasma Protein Binding (PPB): | 94.81% |
Volume Distribution (VD): | 1.019 | Fu: | 5.69% |
CYP1A2-inhibitor: | 0.045 | CYP1A2-substrate: | 0.523 |
CYP2C19-inhibitor: | 0.367 | CYP2C19-substrate: | 0.829 |
CYP2C9-inhibitor: | 0.423 | CYP2C9-substrate: | 0.712 |
CYP2D6-inhibitor: | 0.406 | CYP2D6-substrate: | 0.636 |
CYP3A4-inhibitor: | 0.312 | CYP3A4-substrate: | 0.771 |
Clearance (CL): | 1.834 | Half-life (T1/2): | 0.491 |
hERG Blockers: | 0.04 | Human Hepatotoxicity (H-HT): | 0.544 |
Drug-inuced Liver Injury (DILI): | 0.446 | AMES Toxicity: | 0.709 |
Rat Oral Acute Toxicity: | 0.204 | Maximum Recommended Daily Dose: | 0.086 |
Skin Sensitization: | 0.913 | Carcinogencity: | 0.048 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.01 |
Respiratory Toxicity: | 0.166 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002968 | 0.733 | D04UTT | 0.314 | ||||
ENC002862 | 0.447 | D09WKB | 0.297 | ||||
ENC002966 | 0.443 | D0OB1J | 0.295 | ||||
ENC004800 | 0.439 | D0D1DI | 0.289 | ||||
ENC002861 | 0.431 | D04KJO | 0.289 | ||||
ENC002967 | 0.424 | D0Q1IT | 0.289 | ||||
ENC003768 | 0.417 | D0Q0PR | 0.289 | ||||
ENC002969 | 0.417 | D06BLQ | 0.271 | ||||
ENC003113 | 0.387 | D0R1RS | 0.270 | ||||
ENC004319 | 0.384 | D04BCB | 0.268 |